共 50 条
- [41] Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese populationFrontiers of Medicine, 2016, 10 : 437 - 443Xin Du论文数: 0 引用数: 0 h-index: 0机构: Guangdong Academy of Medical Sciences,Department of Hematology, Guangdong General HospitalDaobin Zhou论文数: 0 引用数: 0 h-index: 0机构: Guangdong Academy of Medical Sciences,Department of Hematology, Guangdong General Hospital
- [42] COMPASSIONATE USE PROGRAM (CUP) WITH RUXOLITINIB IN PATIENTS WITH PRIMARY MYELOFIBROSIS (PMF), POST-POLYCYTHEMIA VERA MYELOFIBROSIS (PPV-MF), AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (PET-MF)HAEMATOLOGICA, 2013, 98 : 765 - 766Vargas, P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Angeles Pedregal, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoKarpovitch, X.论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Nutr & Ciencias Med Salvador Zubiran, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoAlvarado, M.论文数: 0 引用数: 0 h-index: 0机构: ISSSTE Ctr Med Nacl 20 Noviembre, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoOvilla, R.论文数: 0 引用数: 0 h-index: 0机构: Hosp Angeles Lomas, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoAgreda, G.论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Nutr & Ciencias Med Salvador Zubiran, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoGuzman, P.论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Nutr & Ciencias Med Salvador Zubiran, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoSolis, J.论文数: 0 引用数: 0 h-index: 0机构: UMAE HE CMN Gral Div Manuel Avila Camacho IMSS, Hematol, Puebla, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoKassack, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Gen Mexico OD, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoSilva, S.论文数: 0 引用数: 0 h-index: 0机构: ISSSTE Hosp 1 Octubre, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoZavala, S.论文数: 0 引用数: 0 h-index: 0机构: Hosp Star Med, Hematol, Merida, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoMorales, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Reg Merida ISSSTE, Hematol, Merida, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoHerrera, A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Reg Merida ISSSTE, Hematol, Merida, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoReynoso, E.论文数: 0 引用数: 0 h-index: 0机构: Hosp Espanol Mexico, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoRodriguez, M.论文数: 0 引用数: 0 h-index: 0机构: Clin Merida, Hematol, Merida, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoRuiz, G.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hematol & Med Interna Puebla, Hematol, Puebla, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoSobrevilla, P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Angeles Pedregal, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoGarcia, M.论文数: 0 引用数: 0 h-index: 0机构: ISSSTE Hosp 1 Octubre, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoAguilar, C.论文数: 0 引用数: 0 h-index: 0机构: Hosp Reg Valentin Gomez F ISSSTE, Hematol, Zapopan, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoMorales, R.论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Biomed, Hematol, Puerto Vallarta, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoBarrera, E.论文数: 0 引用数: 0 h-index: 0机构: Hosp Civil Viejo Fray Antonio Alcalde, Hematol, Guadalajara, Jalisco, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoOsuna, A.论文数: 0 引用数: 0 h-index: 0机构: IMSS Clin 110, Hematol, Guadalajara, Jalisco, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoCarrillo, R.论文数: 0 引用数: 0 h-index: 0机构: Nucleo Med, Hematol, Guadalajara, Jalisco, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoSilos, G.论文数: 0 引用数: 0 h-index: 0机构: IMSS San Luis Potosi, Hematol, San Luis Potosi, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoVega, A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Bernardette, Hematol, Guadalajara, Jalisco, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoCuin, S.论文数: 0 引用数: 0 h-index: 0机构: Ctr Med Alteno, Hematol, Guadalajara, Jalisco, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoMora, M.论文数: 0 引用数: 0 h-index: 0机构: IMSS Morelia, Hematol, Morelia, Michoacan, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoBest, C.论文数: 0 引用数: 0 h-index: 0机构: Hosp Gen Occidente Seguro Social, Hematol, Guadalajara, Jalisco, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoMurillo, E.论文数: 0 引用数: 0 h-index: 0机构: Hosp Gen Queretaro, Hematol, Queretaro, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoLoarca, L.论文数: 0 引用数: 0 h-index: 0机构: Hosp Angeles Queretaro, Hematol, Queretaro, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoPerez, O.论文数: 0 引用数: 0 h-index: 0机构: Nucleo Med, Hematol, San Luis Potosi, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoSalazar, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Angeles San Luis Potosi, Hematol, San Luis Potosi, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoBaez, E.论文数: 0 引用数: 0 h-index: 0机构: UMAE 25 IMSS Monterrey, Hematol, Monterrey, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoMontemayor, J.论文数: 0 引用数: 0 h-index: 0机构: Opc Oncol, Hematol, Monterrey, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoBarrera, D.论文数: 0 引用数: 0 h-index: 0机构: HU UANL Monterrey, Hematol, Monterrey, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoGarcia, J.论文数: 0 引用数: 0 h-index: 0机构: UMAE 71 IMSS Torreon, Hematol, Torreon, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoPeraza, L.论文数: 0 引用数: 0 h-index: 0机构: UMAE 71 IMSS Torreon, Hematol, Torreon, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoBaltazar, S.论文数: 0 引用数: 0 h-index: 0机构: UMAE 25 IMSS Monterrey, Hematol, Monterrey, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoIniguez, L.论文数: 0 引用数: 0 h-index: 0机构: Novartis Oncol, Hematol, Guadalajara, Jalisco, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoOseguera, R.论文数: 0 引用数: 0 h-index: 0机构: Novartis Oncol, Hematol, Monterrey, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoNacho, K.论文数: 0 引用数: 0 h-index: 0机构: Novartis Oncol, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, MexicoRomero, T.论文数: 0 引用数: 0 h-index: 0机构: Novartis Oncol, Hematol, Mexico City, DF, Mexico Hosp Angeles Pedregal, Hematol, Mexico City, DF, Mexico
- [43] Interim Analysis of a Phase II Pilot Trial of Ruxolitinib Combined with Danazol for Patients with Primary Myelofibrosis (MF), Post Essential Thrombocythemia-Myelofibrosis (Post ET), and Post Polycythemia Vera Myelofibrosis (PV MF) Suffering from AnemiaBLOOD, 2014, 124 (21)Gowin, Krisstina L.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Canc Ctr, Scottsdale, AZ USA Mayo Clin Canc Ctr, Scottsdale, AZ USADueck, Amylou C.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Scottsdale, AZ USA Mayo Clin Canc Ctr, Scottsdale, AZ USAMascarenhas, John O.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, New York, NY 10029 USA Mayo Clin Canc Ctr, Scottsdale, AZ USAHoffman, Ronald论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, New York, NY USA Mayo Clin Canc Ctr, Scottsdale, AZ USAReeder, Craig B.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Arizona, Scottsdale, AZ USA Mayo Clin Canc Ctr, Scottsdale, AZ USACamoriano, John论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Scottsdale, AZ USA Mayo Clin Canc Ctr, Scottsdale, AZ USAGano, Katherine论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Scottsdale, AZ USA Mayo Clin Canc Ctr, Scottsdale, AZ USAGhurye, Vineta论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Arizona, Scottsdale, AZ USA Mayo Clin Canc Ctr, Scottsdale, AZ USAReddy, Sravan Nagi论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Arizona, Scottsdale, AZ USA Mayo Clin Canc Ctr, Scottsdale, AZ USAKoenig, Patricia论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Arizona, Scottsdale, AZ USA Mayo Clin Canc Ctr, Scottsdale, AZ USAFauble, Veena论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Arizona, Phoenix, AZ USA Mayo Clin Canc Ctr, Scottsdale, AZ USATibes, Raoul论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Arizona, Scottsdale, AZ USA Mayo Clin Canc Ctr, Scottsdale, AZ USAMesa, Ruben论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Canc Ctr, Scottsdale, AZ USA Mayo Clin Canc Ctr, Scottsdale, AZ USA
- [44] Phase II study of CEP701, an orally available JAK2 inhibitor, in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosisBLOOD, 2007, 110 (11) : 1037A - 1037AVerstovsek, Srdan论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USA MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USATefferi, Ayalew论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USAKorriblau, Steven论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USA MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USAThomas, Deborah论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USA MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USACortes, Jorge论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USA MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USARavandi-Kashani, Farhad论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USA MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USAGarcia-Manero, Guillermo论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USA MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USAKantarjian, Hagop论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USA MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USA
- [45] PHASE II STUDY OF CEP-701, AN ORALLY AVAILABLE JAK2 INHIBITOR, IN PATIENTS WITH PRIMARY MYELOFIBROSIS AND POST POLYCYTHEMIA VERA/ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSISHAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 439 - 439Santos, F. P. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKantarjian, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAJain, N.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAThomas, D.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAGarcia-Manero, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USACortes, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAVerstovsek, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
- [46] An Individual Patient Supply Program for Ruxolitinib for the Treatment of Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF)BLOOD, 2012, 120 (21)Barosi, Giovanni论文数: 0 引用数: 0 h-index: 0机构: IRCCS Policlin San Matteo Fdn, Pavia, Italy IRCCS Policlin San Matteo Fdn, Pavia, ItalyAgarwal, Mohan论文数: 0 引用数: 0 h-index: 0机构: Bombay Hosp & Med Res Ctr, Mumbai, Maharashtra, India IRCCS Policlin San Matteo Fdn, Pavia, ItalyZweegman, Sonja论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands IRCCS Policlin San Matteo Fdn, Pavia, ItalyWillenbacher, Wolfgang论文数: 0 引用数: 0 h-index: 0机构: Med Univ Innsbruck, A-6020 Innsbruck, Austria IRCCS Policlin San Matteo Fdn, Pavia, ItalyPakstyte, Sima论文数: 0 引用数: 0 h-index: 0机构: Vilnius Univ Hosp Santariskiu Clin, Vilnius, Lithuania IRCCS Policlin San Matteo Fdn, Pavia, ItalyRaymakers, Reinier论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr, Utrecht, Netherlands IRCCS Policlin San Matteo Fdn, Pavia, ItalyCantoni, Nathan论文数: 0 引用数: 0 h-index: 0机构: Kantonsspital Aarau, Univ Clin Med, Aarau, Switzerland IRCCS Policlin San Matteo Fdn, Pavia, ItalyModi, Ankur论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA IRCCS Policlin San Matteo Fdn, Pavia, ItalyKhan, Mahmudul论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA IRCCS Policlin San Matteo Fdn, Pavia, ItalyPerez, Jose Ricardo论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA IRCCS Policlin San Matteo Fdn, Pavia, Italy论文数: 引用数: h-index:机构:Vargas Viveros, Jose Pablo论文数: 0 引用数: 0 h-index: 0机构: Hosp Angeles del Pedregal, Mexico City, DF, Mexico IRCCS Policlin San Matteo Fdn, Pavia, ItalyLinardi, Camila C. G.论文数: 0 引用数: 0 h-index: 0机构: Fac Med USP, Hosp Clin, Sao Paulo, Brazil IRCCS Policlin San Matteo Fdn, Pavia, Italy论文数: 引用数: h-index:机构:Daumas Gabriel, Adelmo Henrique论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Fluminense, Antonio Pedro Univ Hosp, Niteroi, RJ, Brazil IRCCS Policlin San Matteo Fdn, Pavia, ItalyPalandri, Francesca论文数: 0 引用数: 0 h-index: 0机构: Univ Bologna, St Orsola Malpighi Hosp, Inst Hematol Seragnoli, Bologna, Italy IRCCS Policlin San Matteo Fdn, Pavia, ItalyLavie, David论文数: 0 引用数: 0 h-index: 0机构: Hadassah Med Ctr, IL-91120 Jerusalem, Israel IRCCS Policlin San Matteo Fdn, Pavia, ItalyHarrison, Claire N.论文数: 0 引用数: 0 h-index: 0机构: Guys & St Thomas NHS FoundationTrust, London, England IRCCS Policlin San Matteo Fdn, Pavia, Italy
- [47] Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosisHAEMATOLOGICA, 2016, 101 (10) : E405 - E406Gowin, Krisstina论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Arizona, Dept Hematol, Scottsdale, AZ 85259 USA Mayo Clin Arizona, Dept Hematol, Scottsdale, AZ 85259 USACoakley, Maria论文数: 0 引用数: 0 h-index: 0机构: Cork Univ Hosp, Dept Med Oncol, Cork, Ireland Mayo Clin Arizona, Dept Hematol, Scottsdale, AZ 85259 USAKosiorek, Heidi论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Arizona, Dept Hlth Sci Res, Sect Biostat, Scottsdale, AZ USA Mayo Clin Arizona, Dept Hematol, Scottsdale, AZ 85259 USAMesa, Ruben论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Arizona, Dept Hematol, Scottsdale, AZ 85259 USA Mayo Clin Arizona, Dept Hematol, Scottsdale, AZ 85259 USA
- [48] A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosisHAEMATOLOGICA, 2014, 99 (01)Andersen, Christen L.论文数: 0 引用数: 0 h-index: 0机构: Roskilde Univ Hosp, Dept Hematol, Roskilde, Denmark Roskilde Univ Hosp, Dept Hematol, Roskilde, DenmarkMortensen, Nana B.论文数: 0 引用数: 0 h-index: 0机构: Roskilde Univ Hosp, Dept Hematol, Roskilde, Denmark Roskilde Univ Hosp, Dept Hematol, Roskilde, DenmarkKlausen, Tobias W.论文数: 0 引用数: 0 h-index: 0机构: Herlev Univ Hosp, Dept Hematol, DK-2730 Herlev, Denmark Roskilde Univ Hosp, Dept Hematol, Roskilde, Denmark论文数: 引用数: h-index:机构:Bjerrum, Ole W.论文数: 0 引用数: 0 h-index: 0机构: Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Copenhagen, Denmark Roskilde Univ Hosp, Dept Hematol, Roskilde, DenmarkHasselbalch, Hans C.论文数: 0 引用数: 0 h-index: 0机构: Roskilde Univ Hosp, Dept Hematol, Roskilde, Denmark Roskilde Univ Hosp, Dept Hematol, Roskilde, Denmark
- [49] The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post-Essential Thrombocythemia Myelofibrosis (PET-MF)BLOOD, 2012, 120 (21)论文数: 引用数: h-index:机构:Harrison, Claire N.论文数: 0 引用数: 0 h-index: 0机构: Guys & St Thomas NHS FoundationTrust, London, England Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North IrelandNiederwieser, Dietger论文数: 0 引用数: 0 h-index: 0机构: Univ Leipzig, D-04109 Leipzig, Germany Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North IrelandDemuynck, Hilde论文数: 0 引用数: 0 h-index: 0机构: Heilig Hartziekenhuis Roeselare Menen, Roeselare, Belgium Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North IrelandJakel, Nadja论文数: 0 引用数: 0 h-index: 0机构: Univ Leipzig, D-04109 Leipzig, Germany Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North IrelandSirulnik, Andres论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North IrelandMcQuity, Mari论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Basel, Switzerland Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North IrelandStalbovskaya, Viktoriya论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Basel, Switzerland Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North IrelandRecher, Christian论文数: 0 引用数: 0 h-index: 0机构: Univ Toulouse, Toulouse, France Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North IrelandTheunissen, Koen论文数: 0 引用数: 0 h-index: 0机构: Limburgs Oncol Ctr, Hasselt, Belgium Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland论文数: 引用数: h-index:机构:Kiladjian, Jean-Jacques论文数: 0 引用数: 0 h-index: 0机构: Hop St Louis, Paris, France Univ Paris Diderot, Paris, France Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North IrelandAl-Ali, Haifa-Kathrin论文数: 0 引用数: 0 h-index: 0机构: Univ Leipzig, D-04109 Leipzig, Germany Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland
- [50] Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosisLEUKEMIA RESEARCH, 2022, 119Lucijanic, Marko论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, Croatia Univ Zagreb, Sch Med, Ul Salata 3, Zagreb 10000, Croatia Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, Croatia论文数: 引用数: h-index:机构:Soric, Ena论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, Croatia Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, CroatiaSabljic, Anica论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, Croatia Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, CroatiaGalusic, Davor论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Split, Dept Hematol, Soltanska Ul 1, Split 21000, Croatia Univ Split, Sch Med, Soltanska Ul 2, Split 21000, Croatia Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, CroatiaHolik, Hrvoje论文数: 0 引用数: 0 h-index: 0机构: Dr Josip Bencevic Gen Hosp, Dept Internal Med, Ul Andrije Stampara, Slavonski Brod 35000, Croatia Univ Osijek, Fac Med, Ul Josipa Huttlera 4, Osijek 31000, Croatia Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, CroatiaPerisa, Vlatka论文数: 0 引用数: 0 h-index: 0机构: Univ Osijek, Fac Med, Ul Josipa Huttlera 4, Osijek 31000, Croatia Osijek Univ Hosp, Dept Hematol, Ul Josipa Huttlera 4, Osijek 31000, Croatia Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, CroatiaPeric, Martina Moric论文数: 0 引用数: 0 h-index: 0机构: Gen Hosp Zadar, Dept Internal Med, Hematol Dept, Sch Med, Ul Boze Pericica 5, Zadar 23000, Croatia Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, CroatiaZekanovic, Ivan论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, CroatiaKusec, Rajko论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, Croatia Univ Zagreb, Sch Med, Ul Salata 3, Zagreb 10000, Croatia Univ Hosp Dubrava, Hematol Dept, Ave Gojka Suska 6, Zagreb 10000, Croatia